-
Mental healthcare use declined after hormone therapy initiation
Population-based study of mental health treatment patterns in transgender and gender diverse Australians following gender affirming hormone therapy using administrative health records.
-
Zuranolone was approved for postpartum depression, not major depressive disorder
Analysis of zuranolone approval reveals how fast-track designations and reduced evidentiary thresholds in drug regulation may inadequately balance innovation with public health protection.
-
Meloxicam approval in cats is questioned over kidney risk and missing trial data
Examine injectable meloxicam approval for cats, regulatory data discrepancies, acute kidney injury risks, and pharmaceutical sponsorship conflicts in veterinary medicine.
